Drug Trial Radar · NCT04925674
Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis.
Last checked: Nov 19, 2026Latest source record: May 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Sep 10, 2021
Primary completion
Oct 19, 2022
Study completion Oct 19, 2022
Sponsor
- Lead sponsor
- Sunshine Lake Pharma Co., Ltd.Industry
- Sponsor type
- Industry
- Collaborators
- Nicoya Therapeutics (Shanghai) Co., Ltd.
- First posted
- Jun 14, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HEC53856 capsules on anemia in subjects with chronic kidney disease on dialysis.
Conditions
- Hemodialysis
- Peritoneal Dialysis
Interventions
HEC53856Drug
The 100mg dose cohort in the hemodialysis: D1 single oral administration of the investigation product 2.5h before hemodialysis; Three times a week for 6 weeks starting from D8, oral administration of the test drug 2.5h after hemodialysis. The rest dose cohorts in the hemodialysis: Three times a week for 6 weeks starting from D1, oral administration of the investigation product 2.5h after hemodialysis. The dose cohort in the peritoneal dialysis: Three times a week for 6 weeks starting from D1, oral administration of the investigation product after fasting.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse EventsTime frame: Up to 2 weeks after last dose
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Sichuan Provincial People's Hospital
Chengdu, China
The First Affiliated Hospital of Shantou University Medical College
Shantou, China
The First Hospital of China Medical University
Shenyang, China
General Hospital of Tianjin Medical University
Tianjin, China
Affiliated Hospital of Guangdong Medical University
Zhanjiang, China
The Fifth Affiliated Hospital Sun Yat-sen University
Zhuhai, China
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.